uterus during these steps. [5] [6] [7] [8] Since a previous study showed that implantation failure causes 75% of failed conceptions, 9 it is necessary to elucidate the mechanism of implantation failure for the purpose of increasing the rate of pregnancy and live birth.
In implantation studies, researchers have often used animals, especially mice. 5, 8 Recent genetically engineered mouse models rendered valuable information about the detailed mechanisms in embryo implantation. [10] [11] [12] This article introduces the evidence of embryo implantation to help better understanding molecular mechanisms of embryo implantation.
| HORMONAL CONTROL OF EMB RYO IMPL ANTATI ON IN MICE
Progesterone (P 4 ) plays a key role in each step of pregnancy. [10] [11] [12] [13] After ovulation, ovarian corpus luteum secretes P 4 . Luteolysis is inhibited by successful implantation, and corpus luteum keeps secreting P 4. In mice, vaginal plug is seen in the morning on the next day of mating and ovulation, and this day is defined as day 1 of pregnancy.
The luminal epithelium proliferates prominently, and the uterus looks swollen under the influence of 17β-estradiol (E 2 ) surge. Serum P 4 level is increased on day 3 of pregnancy because newly formed corpus luteum starts to produce P 4 markedly after ovulation. By day 4 morning, P 4 overcomes E 2 as a dominant hormone and heightened P 4 provides uterine receptivity to the embryo. The luminal epithelium declines to proliferate and concurrently differentiates; on the other hands, stroma starts to proliferate, 14 and this event is called as uterine proliferation-differentiation switching (PDS). A minor E 2 surge with high circulating levels of P 4 on late day 4 morning initiates embryo-uterine communications on day 4 evening. Dormant blastocysts are activated by E 2 , and the uterus becomes receptive.
Therefore, both receptive uterus and competent blastocysts are required for the molecular and cellular communications with each other under the influence of ovarian steroids. 5, 8 Then, an intimate adherence of the trophectoderm to the luminal epithelium takes place on day 4 midnight. Stromal cells neighboring the blastocyst start differentiation, change their morphology into the epithelioid shape, and produce a new layer surrounding the blastocyst. This is the process of decidualization. The attachment reaction is accompanied by the increase in stromal vascular permeability at the site of the blastocyst, where can be visualized by Chicago blue dye solution which is injected intravenously. On day 5 evening, trophoblast cells enter the stromal layer of the endometrium. Thus, embryo implantation is completed.
5,8,15

| UTERINE PDS AND RECEP TIVIT Y IN MICE
The following two components are essential for successful embryo implantation: a competent blastocyst and uterine receptivity. The latter is defined as a capacity to accept the competent blastocyst in the uterus. 5, 8 Low-quality embryo causes implantation failure. 16 The uterus with receptivity to the embryo shows a suitable uterine preparation with epithelial differentiation and stromal proliferation called as PDS, which is stimulated by ovarian steroids and a hallmark of uterine receptivity ( Figure 1 ). 14 is controlled by uterine receptivity precisely, and uterine PDS is a major indicator of uterine receptivity.
| P -PR S I G NALING IN EMB RYO I M PL A NTATI O N
In the clinical setting, progestin including P 4 improves implantation rate by supporting the function of corpus luteum; therefore, details of P 4 action should be clarified to develop new approaches to the infertility treatment.
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P 4 acts through P 4 receptor (PR), a nuclear receptor, transcriptionally controlling the P 4 responsive genes and the important pathways for pregnancy events, such as ovulation and implantation. 5, 18 Studies using the mouse models targeting PR and its related molecules gradually revealed P 4 roles in pregnancy. PR null female mice are infertile due to ovulation failure, 10 indicating that P 4 -PR signaling is crucial for ovulation. Thus, PR knockout mouse is a useful model to analyze the molecular pathways in ovulation. However, this model cannot clarify the effects of P 4 on embryo implantation.
PR function is influenced by the stability of PR complex.
Functionally, mature PR complex consists of a receptor monomer, a 90-kDa heat shock protein (Hsp90) dimer, a cochaperone p23, and one of four cochaperones which include tetratricopeptide repeat (TPR) that binds to Hsp90. 19 The immunophilin cochaperone 52-kDa FK506 binding protein (FKBP52) is one of such TPR-containing cochaperones, binding both Hsp90 and PR, stabilizing the structure of PR complex, and enhancing P 4 -PR signaling. 12, 19, 20 FKBP52 null mice are infertile specifically due to defected implantation resulting from the impairment of uterine receptivity. Deficiency of FKBP52 diminishes uterine P 4 -PR signaling. It does not break up the signal completely, because minimal binding of P 4 to PR is still alive. 12, 19, 20 Excessive P 4 administration can rescue uterine PR signaling in FKBP52 deficient mice on the CD1 background. This is not a remarkable aspect of PR knockout mice, but that of FKBP52 null mice. 12 Moreover, FKBP52 null mice show normal ovulation with normal P 4 secretion. 12 Therefore, FKBP52 deficient mouse is a well-established unique model with uterine "P 4 resistance," which means that P 4 responsiveness is diminished, but is reversible with P 4 administration. Taken together, P 4 -PR signaling is a crucial pathway for embryo implantation.
| P 4 -PR S I G NALING CONTROL S UTERINE PDS AND RECEP TIVIT Y
Uterine PDS in the receptive uterus is observed in humans as well as in mice.
14 Generally speaking, cell differentiation and poor cell proliferation can be observed simultaneously, and distinct switching between proliferation and differentiation occurs in many cell types. [21] [22] [23] [24] Our previous study showed that FKBP52 null mice have continuous epithelial proliferation without enhanced stromal proliferation on day 4 morning, and these phenotypes are recovered by P 4 supplementation, indicating uterine P 4 resistance in FKBP52 knockout mice. PR antagonist RU486 injection in the peri-implantation period hampers uterine PDS and embryo implantation in wild-type (WT) mice. 14 According to the previous literature, implantation failure occurs in all types of mice with impaired uterine PDS. 14, 15, 19, [25] [26] [27] [28] [29] 
PR has two isoforms, PR-A and PR-B. Previous studies demonstrated
that PR-A is mainly associated with uterine function during pregnancy, contributing to uterine PDS. 11, 30 In contrast, PR-B null mice have normal pregnancy outcome, which is presumed that PR-B does
is not important for pregnancy process. These findings suggest that P 4 -PR-A signaling governs uterine receptivity by controlling uterine PDS (Figures 1 and 2 ).
| APPROPRIATE BAL AN CE B E T WEEN E 2 AND P 4 IS NECE SSARY FOR UTERINE PDS AND RECEP TIVIT Y
The regulation of appropriate balance between E 2 and P 4 is a delicate mechanism to induce uterine PDS. In mice, a spike of E 2 secretion from ovary just before implantation strictly controls the "implantation window." Neither lack nor excess of E 2 level can open the implantation window. 31 In the condition of excess E 2 -estrogen receptor (ER) signaling in humans, implantation failure occurs at higher rates. [32] [33] [34] [35] Abnormal balance between E 2 -ER signaling and P 4-PR signaling leads to implantation failure in the mouse models other than FKBP52 deficient mice. In mice with uterine deficiency of nuclear receptor co-activator 2 (NCOA2), gene encoding steroid receptor co-activator 2 (SRC2), the disrupt of the optimization of PR function by NCOA2 causes implantation failure. 36 Although previous in vitro studies demonstrated that nuclear receptor co-activator 6 (NCOA6) interacts with ERα as a co-activator, [37] [38] [39] [40] an in vivo study reported that NCOA6 does not work as co-activator but induces the ubiquitination and degradation of ERα, diminishing E 2 -ER signaling in the peri-implantation period 27 ( Figure 1 ). By uterine deletion of NCOA6, ERα is accumulated and E 2 sensitivity is enhanced, Figure 1 ).
Uterine-specific deletion of signal transducer and activator of transcription 3 (STAT3), known as a downstream molecule of leukemia inhibitory factor (LIF) before implantation, 41 also induces implantation failure due to the effect of E 2 -ER signaling rather than that of P 4 -PR signaling in the peri-implantation period, 42 but the minute interaction between STAT3 and E 2/ P 4 signaling is not fully revealed.
A recent study of mouse models demonstrated that uterine ablation of the polycomb group gene BMI1, a component of the polycomb repressive complex-1 (PRC1), induces implantation failure due to uterine P 4 responsiveness. 29 BMI1 interacts with PR and E3 ligase E6AP in a polycomb complex-independent manner and controls PR ubiquitination. 29 In women who had a spontaneous miscarriage, low BMI1 expression in endometrium is correlated with poor PR responsiveness. 29 Thus, BMI1 controls uterine PR function under the posttranscriptional modification and contributes to successful embryo implantation in mice and humans ( Figure 1 ).
| P 4 -INDUCED UTERINE PDS IS MOD IFIED BY HAND2 , IHH , AND EG R1
Heart and neural crest derivatives-expressed protein 2 (HAND2), one of basic helix-loop-helix transcription factors, in the uterine stroma, influences P 4 -PR signaling and hampers epithelial proliferation by blocking the stromal expression of fibroblast growth factor, whereas it does not have effect on stromal proliferation.
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HAND2 has a role of a blocker of epithelial E 2 signaling, permitting the preparation of the uterine epithelium for embryo implantation.
Uterine deletion of HAND2 leads to impairment of embryo attachment, suggesting that HAND2 in the stroma regulates embryo attachment through the process of epithelial differentiation induced by P 4 ( Figure 1 ).
Indian hedgehog (IHH) is a downstream factor of PR and is highly
expressed in the uterine luminal epithelium of WT mice just before embryo attachment, and also in the endometrium of humans with the progestin treatment. [43] [44] [45] IHH works through its receptor patched-1 (PTCH1), localized in the uterine stroma, and prompts to stromal proliferation. [43] [44] [45] The downstream targets of IHH pathway are GLI, which is one of transcriptional factors, and a nuclear receptor chicken ovalbumin upstream promoter-transcriptional factor (COUP-TFII). 43, 46 GLI may contribute to stromal proliferation, 43 and COUP-TFII may keep the appropriate balance between the ER and PR signaling 46 ( Figure 1 ). These findings suggest the presence of complicated but regulated interaction between uterine epithelium and stroma under hormonal control.
Another recent study showed that early growth response 1 (EGR1) null female mice are completely infertile due to implantation failure. 47 EGR1 belongs to the EGR family of zinc finger transcription factors which participate in the regulation of cell proliferation, differentiation, and apoptosis. 48, 49 EGR1 is induced in both epithelial cells and stromal cells by E 2 through the ERα-ERK1/2 pathway in the uterus 50 ( Figure 1 ) and also induced in the subluminal stromal cells surrounding the implanting blastocyst. 50, 51 In EGR1 null mice, the expression of PR in epithelial cells is aberrantly reduced, E 2 activity is enhanced, and P 4 response is impaired. 47 Furthermore, the uterus of EGR1 null mice demonstrated continuous proliferation of luminal epithelial cells and poor proliferation of stromal cells, 47 indicating that impaired uterine PDS in EGR1 null mice. These findings suggest that E 2 induces EGR1 to fine-tune its actions on uterine epithelium by controlling P 4 -PR signaling in order to acquire uterine receptivity.
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| UTERINE MI CRORNA REG UL ATE S P 4 -PR S I G NALING AND PDS EPI G ENE TI C ALLY
We previously demonstrated that PDS takes place in a spatial manner, between the uterine corpus and cervix. 14 The place where blastocyst implantation occurs under the normal pregnancy is the endometrium in the uterine corpus, but not the uterine cervix. In the peri-implantation period, PDS is recognized in the mouse uterine corpus, but not in the uterine cervix. The human endometrium in the uterine corpus also exhibits dynamic PDS from the proliferative phase to the secretory phase, while the human uterine cervix does not show any significant changes of the proliferation status. 14 Based on these findings, we speculated the presence of distinct regulation system of P 4 -PR signaling between the uterine corpus and cervix.
Interestingly, we found that P 4 
| EMB RYO AT TACHMENT IS REG UL ATED BY UTERINE FOX A 2-LIF PATHWAY AND PL ANAR CELL P OL ARIT Y (P CP) S I G NALING
Forkhead Box A2 (FOXA2) controls embryo attachment, 53 and
Vang-like protein 2 (VANGL2) induces crypt formation of implantation sites and appropriate embryo attachment. 54 As described above, E 2 is an initiator for embryo attachment. Leukemia inhibitory factor (LIF), an interleukin-6 (IL-6) family cytokine, is produced by endometrial glands in response to E 2 secreted by ovaries and has a very important role in embryo attachment. In a delayed implantation mouse model, which is ovariectomized on day 4 of pregnancy and received hormone supplementation later, LIF causes embryo attachment instead of E 2 . 55 A recent study revealed that FOXA2
is expressed in the uterine glandular epithelium and essential for uterine glands development in neonatal mice. 53 FOXA2 deletion in the entire uterus and in the epithelium causes complete loss of uterine gland, and embryo attachment failure due to LIF reduction, respectively. 53 Attachment failure in the latter mice is recovered by LIF supplementation. 53 Taken together, E 2 -FOXA2-LIF pathway has a critical role in embryo attachment ( Figure 2 ).
In mice, embryo attachment occurs at the bottom of crypts, which originate as epithelial evaginations from the main lumen at orderly spaced intervals. 54 However, the mechanism of epithelial evaginations was not clarified. Planar cell polarity (PCP) is known as a controller which directs actin-dependent morphogenetic cell movement to polarize structures in a wide range of settings. 56 A recent study showed that VANGL2, which is a core PCP component and works to execute PCP signaling in collaboration with many other molecules, has a crucial role in uterine crypt formation and embryo attachment 54 ( Figure 1 ). The litter size is significantly reduced in mice with uterine VANGL2 deletion. Uterine deletion of VANGL2 confers aberrant PCP signaling, misdirected epithelial evaginations, defective crypt formation, and embryo attachment, leading to severely compromised pregnancy outcomes. 54 These findings suggest that PCP signaling is crucial for embryo implantation (Figure 2 ).
| EMB RYO INVA S I ON IS REG UL ATED BY HIF2α IN THE S TROMA
The mechanisms of embryo invasion have not been elucidated.
Since the surface of the endometrium is far from uterine blood vessels, it is possible that oxygen concentration in the luminal epithelium is relatively low compared with the inner endometrium.
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Therefore, it is speculated that the surface of endometrium is in hypoxic state during embryo implantation. Hypoxia-inducible factor (HIF) is a common transcriptional factor induced by low oxygen tension. 58 In mice, uterine HIF2α expression is intense during periimplantation period. 59 We recently revealed that entire uterine deletion of HIF2α results in implantation failure due to embryo invasion failure in mice 15 
| CON CLUS ION
The number of women who conceived by IVF-ET increased markedly for years. To improve fertility rate in IVF-ET treatment, there remain many issues to be solved, such as recurrent implantation failure despite transfer of good-quality embryos. 6, 60 Implantation failure accounts for a major cause of unexplained infertility, and to date, no efficient treatments exist. Many molecules functioning within the very limited duration are associated with the formation of implantation window, and fundamental research is necessary for elucidating the mechanisms of implantation failure and for establishing its effective treatments. "P 4 resistance" is one of the possible mechanisms of implantation failure. 12,19 P 4 supplementation treatment for infertility patients is common in humans, and its effectiveness on patients with luteal insufficiency is established. 17 However, even P 4 supplementation cannot rescue the infertility caused by implantation failure.
Accordingly, the present treatment cannot cure patients with severe P 4 resistance.
Recent mouse studies revealed that embryo implantation contains multistep processes: uterine receptivity, embryo attachment, and embryo invasion. We consider that implantation failure in humans may be often caused by uterine factors with little relation to P 4 -PR signaling involved in each process of embryo implantation such as embryo attachment and embryo invasion, and these patients are out of control of P 4 supplementation. We believe that this concept of multistep processes in embryo implantation must help us to develop novel approaches to infertility and contraception. 
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